Cardiovascular, Renal and Metabolism (CVRM)
Changing conventional thinking in the field of Renal and Metabolism (CVRM)
We aim to save the lives of people who suffer from cardiovascular disease, heart failure, cardiovascular, metabolic and renal diseases by driving solutions that break with conventional thinking. We address shared risk factors between these distinct but interrelated disease areas and view patients holistically and not according to indication.
Up to 18 million
people die from CVRM diseases each year, making them the leading causes of death across the globe.
More than 420 million
people are living with diabetes worldwide. People with type-2 diabetes have an increased risk of cardiovascular disease and comorbidities.
More than 40%
of patients with heart failure also have chronic kidney disease.
Up to 40%
of patients hospitalised for heart failure have diabetes.
Learn more about working at AstraZeneca in Switzerland.